Vorinostat Recruiting Phase 1 Trials for Human Immunodeficiency Virus Type 1 (HIV-1) Infection Prevention

IndicationsStatusPurposePhase
RecruitingPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT03803605Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons